Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorAziret, Mehmet
dc.contributor.authorIrkorucu, Oktay
dc.contributor.authorReyhan, Enver
dc.contributor.authorErdem, Hasan
dc.contributor.authorDas, Koray
dc.contributor.authorÖzkara, Selvinaz
dc.contributor.authorDeger, Kamuran Cumhur
dc.contributor.authorSözen, Selim
dc.contributor.authorBali, İlhan
dc.date.accessioned2022-05-11T14:34:55Z
dc.date.available2022-05-11T14:34:55Z
dc.date.issued2014
dc.identifier.issn1807-5932
dc.identifier.issn1980-5322
dc.identifier.urihttps://doi.org/10.6061/clinics/2014(11)10
dc.identifier.urihttps://hdl.handle.net/20.500.11776/8138
dc.description.abstractOBJECTIVES: Vardenafil enhances dilatation of vascular smooth muscle and inhibits platelet aggregation. The purpose of this study was to evaluate the clinical effects of vardenafil and pentoxifylline administration in an experimental model of ischemic colitis. METHODS: Forty female Wistar albino rats weighing 250-300 g were randomized into five experimental groups (each with n = 8) as follows: 1) a sham group subjected to a sham surgical procedure and administered only tap water; 2) a control group subjected to a standardized surgical procedure to induce ischemic colitis and administered only tap water; 3) and 4) treatment groups subjected to surgical induction of ischemic colitis followed by the postoperative administration of 5 mg/kg or 10 mg/kg vardenafil, respectively; and 5) a treatment group subjected to surgical induction of ischemic colitis followed by postoperative administration of pentoxifylline at 50 mg/kg/day per day as a single dose for a 3-day period. All animals were sacrificed at 72 h post-surgery and subjected to relaparotomy. We scored the macroscopically visible damage, measured the ischemic area and scored histopathology to determine the severity of ischemia. Tissue malondialdehyde levels were also quantified. RESULTS: The mean Gomella ischemic areas were 63.3 mm(2) in the control group; 3.4 and 9.6 mm(2) in the vardenafil 5 and vardenafil 10 groups, respectively; and 3.4 mm(2) in the pentoxifylline group (p = 0.0001). The mean malondialdehyde values were 63.7 nmol/g in the control group; 25.3 and 25.6 nmol/g in the vardenafil 5 and vardenafil 10 groups, respectively; and 22.8 nmol/g in the pentoxifylline group (p = 0.0001). CONCLUSION: Our findings indicate that vardenafil and pentoxifylline are effective treatment options in an animal model of ischemic colitis. The positive clinical effects produced by these drugs are likely due to their influence on the hemodynamics associated with vascular smooth muscle and platelet functions.en_US
dc.language.isoengen_US
dc.publisherHospital Clinicas, Univ Sao Pauloen_US
dc.identifier.doi10.6061/clinics/2014(11)10
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectIschemic Colitisen_US
dc.subjectPDE-5 Inhibitorsen_US
dc.subjectPentoxifyllineen_US
dc.subjectVardenafilen_US
dc.subjectSkin Flap Survivalen_US
dc.subjectReperfusion Injuryen_US
dc.subjectPulmonary-Arteryen_US
dc.subjectOxidative Stressen_US
dc.subjectRat Modelen_US
dc.subjectSildenafilen_US
dc.subjectInhibitoren_US
dc.titleThe effects of vardenafil and pentoxifylline administration in an animal model of ischemic colitisen_US
dc.typearticleen_US
dc.relation.ispartofClinicsen_US
dc.departmentFakülteler, Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Genel Cerrahi Ana Bilim Dalıen_US
dc.authorid0000-0003-2006-9198
dc.authorid0000-0001-6758-7289
dc.authorid0000-0001-8707-5301
dc.authorid0000-0001-9111-2734
dc.identifier.volume69en_US
dc.identifier.issue11en_US
dc.identifier.startpage763en_US
dc.identifier.endpage769en_US
dc.institutionauthorSözen, Selim
dc.institutionauthorBali, İlhan
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.authorscopusid35791793300
dc.authorscopusid8431600000
dc.authorscopusid14042203500
dc.authorscopusid36134374200
dc.authorscopusid48460919300
dc.authorscopusid6603751762
dc.authorscopusid8688819200
dc.authorwosidDAS, Koray/AAD-8537-2021
dc.authorwosidSözen, Selim/ABA-6337-2020
dc.authorwosidirkorucu, oktay/AAL-7383-2020
dc.authorwosidAZİRET, MEHMET/I-5483-2014
dc.authorwosidCetinkunar, Suleyman/AFP-2813-2022
dc.identifier.wosWOS:000346477700010en_US
dc.identifier.scopus2-s2.0-84920432204en_US
dc.identifier.pmid25518035en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster